| Legislation/Issues | Synopsis | Resources | New This Week/Upcoming Dates |
|---|---|---|---|
| SB 144 - Health - Authorization to Prescribe and Administer Amygdalin - Repeal | Repealing certain provisions of law relating to the prescription, administration, and regulation of amygdalin. | SB 144 | Approved by the Governor - Chapter 306 (5/12) SB 144: Hearing 3/23 at 1:30 p.m.@Health and Government Operations SB 144: Hearing 2/10 at 1:00 p.m.@Finance |
| SB 244 (HB 534) - Maryland Medical Assistance Program - Self-Measured Blood Pressure Monitoring | Requiring, beginning January 1, 2023, the Maryland Medical Assistance Program to provide coverage for self-measured blood pressure monitoring. | SB 244 HB 534 | Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 670 (5/29) Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 669 (5/29) SB 244: Hearing 2/08 at 1:00 p.m.@Finance HB 534: Hearing 2/09 at 1:30 p.m.@Health and Government Operations |
| SB 302 (HB 248) - Legionnaires' Disease Prevention Act | Requiring the Department of the Environment to adopt regulations requiring an owner or operator of a public building to establish and implement a water management program to prevent the growth and spread of Legionella pneumophila in a building water system to reduce the risk for Legionnaires' disease; requiring the regulations to be consistent with the American Society of Heating, Refrigerating, and Air-Conditioning Engineers (ASHRAE) standard 188 (Legionellosis: Risk Management for Building Water Systems); etc. | SB 302 HB 248 | Hearing 2/02 at 1:00 p.m. (1/20) Hearing 2/02 at 1:00 p.m. (1/19) SB 302: Hearing 2/02 at 1:00 p.m.@Education, Health, and Environmental Affairs HB 248: Hearing 2/02 at 1:00 p.m.@Environment and Transportation |
| SB 865 - Controlled Dangerous Substances and Treatment of Chronic Pain and Long-Term Oxygen Use Patients (Continuity of Care Act of 2022) | Altering certain requirements related to the provision of information regarding opioid use disorder by the Maryland Department of Health, the prescribing of opioids, and the filling of prescriptions for monitored prescription drugs; establishing certain civil and criminal immunity; requiring a health care provider to make a good-faith effort to maintain the previous dosage of and regimen for a controlled dangerous substance and make certain referrals for a certain patient; etc. | SB 865 | Withdrawn by Sponsor (3/16) |